Meta-analysis of structural brain abnormalities associated with stimulant drug dependence and neuroimaging of addiction vulnerability and resilience

Current Opinion in Neurobiology

Volumn 23, Issue 4, 2013, Pages 615-624

  Ersche, Karen D ^a   Williams, Guy B ^a,b   Robbins, Trevor W ^a   Bullmore, Edward T ^a,c,d  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^c CAMBRIDGESHIRE AND PETERBOROUGH NHS FOUNDATION TRUST   (United Kingdom)

^d GLAXOSMITHKLINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN ATROPHY; BRAIN MALFORMATION; BRAIN REGION; COCAINE DEPENDENCE; COPING BEHAVIOR; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; DRUG DEPENDENCE; GRAY MATTER; HUMAN; METHAMPHETAMINE DEPENDENCE; MORPHINE ADDICTION; NEUROANATOMY; NEUROIMAGING; NONHUMAN; PREFRONTAL CORTEX; PRIORITY JOURNAL; REVIEW; VOXEL BASED MORPHOMETRY;

EID: 84881088617     PISSN: 09594388     EISSN: 18736882     Source Type: Journal    
DOI: 10.1016/j.conb.2013.02.017     Document Type: Review

References (68)

1. Degenhardt L.J. Extent of illicit drug use and dependence, and their contribution to the global burden of disease. Lancet 2012, 379:55-70.
2. Nutt D., King L.A., Saulsbury W., Blakemore C. Development of a rational scale to assess the harm of drugs of potential misuse. Lancet 2007, 369:1047-1053.
3. European Monitoring Centre for Drugs and Drug Addiction Treatment of Problem Cocaine Use: A Review of the Literature 2007, European Monitoring Centre for Drugs and Drug Addiction (EMCDDA), Lisbon, Portugal.
4. Hanlon C.A., Canteberry M. The use of brain imaging to elucidate neural circuit changes in cocaine addiction. Subst Abuse Rehab 2012, 3:115-128.
5. Koob G.F., Volkow N.D. Neurocircuitry of addiction. Neuropsychopharmacology 2010, 35:217-238.
6. Jacobsen L.K., Giedd J.N., Gottschalk C., Kosten T.R., Krystal J.H. Quantitative morphology of the caudate and putamen in patients with cocaine dependence. Am J Psychiatry 2001, 158:486-489.
7. Chang L., Cloak C., Patterson K., Grob C., Miller E.N., Ernst T. Enlarged striatum in abstinent methamphetamine abusers: a possible compensatory response. Biol Psychiat 2005, 57:967-974.
8. Ersche K.D., Barnes A., Jones P.S., Morein-Zamir S., Robbins T.W., Bullmore E.T. Abnormal structure of frontostriatal brain systems is associated with aspects of impulsivity and compulsivity in cocaine dependence. Brain 2011, 134:2013-2024.
9. Jan R., Lin J., Miles S., Kydd R., Russell B. Striatal volume increases in active methamphetamine-dependent individuals and correlation with cognitive performance. Brain Sci 2012, 2:553-572.
10. Jernigan T.L., Gamst A.C., Archibald S.L., Fennema-Notestine C., Mindt M.R., Marcotte T.L., Heaton R.K., Ellis R.J., Grant I. Effects of methamphetamine dependence and HIV infection on cerebral morphology. Am J Psychiatry 2005, 162:1461-1472.
11. Hanlon C., Dufault D., Wesley M., Porrino L. Elevated gray and white matter densities in cocaine abstainers compared to current users. Psychopharmacology (Berl) 2011, 218:681-692.
12. Barros-Loscertales A., Garavan H., Bustamante J.C., Ventura-Campos N., Llopis J.J., Belloch V., Parcet M.A., vila C. Reduced striatal volume in cocaine-dependent patients. Neuroimage 2011, 56:1021-1026.
13. Moreno-Lopez L., Catena A., Fernandez-Serrano M.J., Delgado-Rico E., Stamatakis E.A., Perez-Garcia M., Verdejo-Garcia A. Trait impulsivity and prefrontal gray matter reductions in cocaine dependent individuals. Drug Alcohol Depend 2012, 125:208-214.
14. Narayana P.A., Datta S., Tao G., Steinberg J.L., Moeller F.G. Effect of cocaine on structural changes in brain: MRI volumetry using tensor-based morphometry. Drug Alcohol Depend 2010, 111:191-199.
15. Weller R.E., Stoeckel L.E., Milby J., Bolding M., Twieg D.B., Knowlton R.C., Avison J.M., Ding Z. Smaller regional gray matter volume in homeless African American cocaine-dependent men: a preliminary report. Open Neuroimag J 2011, 5:57-64.
16. Eickhoff S.B., Laird A.R., Grefkes C., Wang L.E., Zilles K., Fox P.T. Coordinate-based activation likelihood estimation meta-analysis of neuroimaging data: a random-effects approach based on empirical estimates of spatial uncertainty. Hum Brain Mapp 2009, 30:2907-2926.
17. Lancaster J.L., Tordesillas-Gutierrez, Martinez M., Salinas F., Evans A., Zilles K., Mazziotta J.C., Fox P.T. Bias between MNI and Talairach coordinates analyzed using the ICBM-152 brain template. Hum Brain Mapp 2007, 28:1194-1205.
18. Rorden C., Karnath H.O., Bonilha L. Improving lesion-symptom mapping. J Cogn Neurosci 2007, 19:1081-1088.
19. Radua J., van den Heuvel O.A., Surguladze S., Mataix-Cols D. Meta-analytical comparison of voxel-based morphometry studies in obsessive-compulsive disorder vs other anxiety disorders. Arch Gen Psychiatry 2010, 67:701-711.
20. Goldstein R.Z., Tomasi D., Rajaram S., Cottone L.A., Zhang L., Maloney T., Telang F., Alia-Klein N., Volkow N.D. Role of the anterior cingulate and medial orbitofrontal cortex in processing drug cues in cocaine addiction. Neuroscience 2007, 144:1153-1159.
21. Medford N., Critchley H.D. Conjoint activity of anterior insular and anterior cingulate cortex: awareness and response. Brain Struct Funct 2010, 214:535-549.
22. Aron A.R., Robbins T.W., Poldrack R.A. Inhibition and the right inferior frontal cortex. Trends Cogn Sci 2004, 8:170-177.
23. Levy D.J., Glimcher P.W. The root of all value: a neural common currency for choice. Curr Opin Neurobiol 2012, 22:1027-1038.
24. Liu X., Hairston J., Schrier M., Fan J. Common and distinct networks underlying reward valence and processing stages: a meta-analysis of functional neuroimaging studies. Neurosci Biobehav Rev 2011, 35:1219-1236.
25. Dom G., Sabbe B., Hulstijn W., Van den Brink W. Substance use disorders and the orbitofrontal cortex-systematic review of behavioural decision-making and neuroimaging studies. Brit J Psychiat 2005, 187:209-220.
26. Clark L., Robbins T.W. Decision-making deficits in drug addiction. Trends Cogn Sci 2002, 6:361-363.
27. Goldstein R.Z., Volkow N.D. Dysfunction of the prefrontal cortex in addiction: neuroimaging findings and clinical implications. Nat Rev Neurosci 2011, 12:652-669.
28. Everitt B.J., Robbins T.W. Neural systems of reinforcement for drug addiction: from actions to habits to compulsion. Nat Neurosci 2005, 8:1481-1489.
29. Adinoff B., Braud J., Devous M.D., Harris T.S. Caudolateral orbitofrontal regional cerebral blood flow is decreased in abstinent cocaine-addicted subjects in two separate cohorts. Addict Biol 2012, 17:1001-1012.
30. Volkow N.D., Chang L., Wang G.J., Fowler J.S., Ding Y.S., Sedler M., Logan J., Franceschi D., Gatley J., Hitzemann R., Gifford A., Wong C., Pappas N. Low level of brain dopamine D-2 receptors in methamphetamine abusers: association with metabolism in the orbitofrontal cortex. Am J Psychiatry 2001, 158:2015-2021.
31. Benes F.M., Paskevich P.A., Davidson J., Domesick V.B. The effects of haloperidol on synaptic patterns in the rat striatum. Brain Res 1985, 329:265-273.
32. Chakos M.H., Shirakawa O., Lieberman J., Lee H., Bilder R., Tamminga C.A. Striatal enlargement in rats chronically treated with neuroleptic. Biol Psychiatry 1998, 44:675-684.
33. Corson P.W., Nopoulos P., Miller D.D., Arndt S., Andreasen N.C. Change in basal ganglia volume over 2 years in patients with schizophrenia: typical versus atypical neuroleptics. Am J Psychiatry 1999, 156:1200-1204.
34. Scherk H., Falkai P. Effects of antipsychotics on brain structure. Curr Opin Psychiatry 2006, 19:145-150.
35. Keshavan M., Bagwell W., Haas G., Sweeney J., Schooler N., Pettegrew J. Changes in caudate volume with neuroleptic treatment. Lancet 1994, 344:1434.
36. Nakao T., Radua J., Rubia K., Mataix-Cols D. Gray matter volume abnormalities in ADHD: voxel-based meta-analysis exploring the effects of age and stimulant medication. Am J Psychiat 2011, 168:1154-1163.
37. Ersche K.D., Jones P.S., Williams G.B., Turton A.J., Robbins T.W., Bullmore E.T. Abnormal brain structure implicated in stimulant drug addiction. Science 2012, 335:601-604.
38. Derauf C., Kekatpure M., Neyzi N., Lester B., Kosofsky B. Neuroimaging of children following prenatal drug exposure. Semin Cell Dev Biol 2009, 20:441-454.
39. Rivkin M.J., Davis P.E., Lemaster J.L., Cabral H.J., Warfield S.K., Mulkern R.V., Robson C.D., Rose-Jacobs R., Frank D.A. Volumetric MRI study of brain in children with intrauterine exposure to cocaine, alcohol, tobacco, and marijuana. Pediatrics 2008, 121:741-750.
40. Roussotte F., Soderberg L., Sowell E. Structural, metabolic, and functional brain abnormalities as a result of prenatal exposure to drugs of abuse: evidence from neuroimaging. Neuropsychol Rev 2010, 20:376-397.
41. Gottesman I.I., Gould T.D. The endophenotype concept in psychiatry: etymology and strategic intentions. Am J Psychiatry 2003, 160:636-645.
42. Thompson P.M., Cannon T.D., Narr K.L., van Erp T., Poutanen V.P., Huttunen M., Lonnqvist J., Standertskjold-Nordenstam C.G., Kaprio J., Khaledy M., Dail R., Zoumalan C.I., Toga A.W. Genetic influences on brain structure. Nat Neurosci 2001, 4:1253-1258.
43. Ersche K.D., Jones P.S., Williams G.B., Smith D.G., Bullmore E.T., Robbins T.W. Distinctive personality traits and neural correlates associated with stimulant drug use versus familial risk of stimulant dependence. Biol Psychiatry 2012, [Epub ahead of print]. 10.1016/j.biopsych.2012.11.016.
44. Cantin L., Lenoir M., Augier E., Vanhille N., Dubreucq S., Serre F., Vouillac C., Ahmed S.H. Cocaine is low on the value ladder of rats: possible evidence for resilience to addiction. PLoS ONE 2010, 5:e11592. 10.1371/journal.pone.0011592.
45. Falck R.S., Wang J., Carlson R.G. Among long-term crack smokers, who avoids and who succumbs to cocaine addiction?. Drug Alcohol Depend 2008, 98:24-29.
46. Bora E., Fornito A., Yucel M., Pantelis C. Voxelwise meta-analysis of gray matter abnormalities in bipolar disorder. Biol Psychiatry 2010, 67:1097-1105.
47. Selvaraj S., Arnone D., Job D., Stanfield A., Farrow T.F.D., Nugent A.C., Scherk H., Gruber O., Chen X.H., Sachdev P.S., Dickstein D.P., Malhi G.S., Ha T.H., Ha K., Phillips M.L., McIntosh A.M. Grey matter differences in bipolar disorder: a meta-analysis of voxel-based morphometry studies. Bipolar Disord 2012, 14:135-145.
48. Ellison-Wright I., Glahn D.C., Laird A.R., Thelen S.M., Bullmore E. The anatomy of first-episode and chronic schizophrenia: an anatomical likelihood estimation meta-analysis. Am J Psychiat 2008, 165:1015-1023.
49. Ellison-Wright I., Bullmore E. Anatomy of bipolar disorder and schizophrenia: a meta-analysis. Schizophr Res 2010, 117:1-12.
50. Bora E., Fornito A., Radua J., Walterfang M., Seal M., Wood S.J., Yucel M., Velakoulis D., Pantelis C. Neuroanatomical abnormalities in schizophrenia: a multimodal voxelwise meta-analysis and meta-regression analysis. Schizophr Res 2011, 127:46-57.
51. Regier D.A., Farmer M.E., Rae D.S., Locke B.Z., Keith S.J., Judd L.L., Goodwin F.K. Comorbidity of mental disorders with alcohol and other drug abuse. Results from the epidemiologic catchment area (ECA) study. JAMA 1990, 264:2511-2518.
52. Ersche K.D., Turton A.J., Pradhan S., Bullmore E.T., Robbins T.W. Drug addiction endophenotypes: impulsive versus sensation-seeking personality traits. Biol Psychiatry 2010, 68:770-773.
53. Ersche K.D., Turton A.J., Chamberlain S.R., Müller U., Bullmore E.T., Robbins T.W. Cognitive dysfunction and anxious-impulsive personality traits are endophenotypes for drug dependence. Am J Psychiat 2012, 169:926-936.
54. Fusar-Poli P., Radua J., McGuire P., Borgwardt S. Neuroanatomical maps of psychosis onset: voxel-wise meta-analysis of antipsychotic-naive VBM studies. Schizophr Bull 2012, 38:1297-1307.
55. Lee S.S., Humphreys K.L., Flory K., Liu R., Glass K. Prospective association of childhood attention-deficit/hyperactivity disorder (ADHD) and substance use and abuse/dependence: a meta-analytic review. Clin Psychol Rev 2011, 31:328-341.
56. Everitt B.J., Belin D., Economidou D., Pelloux Y., Dalley J.W., Robbins T.W. Neural mechanisms underlying the vulnerability to develop compulsive drug-seeking habits and addiction. Philos Trans Roy Soc B 2008, 363:3125-3135.
57. Ellison-Wright I., Ellison-Wright Z., Bullmore E. Structural brain change in attention deficit hyperactivity disorder identified by meta-analysis. BMC Psychiatry 2008, 8:51. 10.1186/1471-244X-8-51.
58. Frodl T., Skokauskas N. Meta-analysis of structural MRI studies in children and adults with attention deficit hyperactivity disorder indicates treatment effects. Acta Psychiatr Scand 2012, 125:114-126.
59. Volkow N.D., Ding Y.S., Fowler J.S., Wang G.J., Logan J., Gatley J.S., Dewey S., Ashby C., Liebermann J., Hitzemann R., Wolf A.P. Is methylphenidate like cocaine-studies on their pharmacokinetics and distribution in the human brain. Arch Gen Psychiatry 1995, 52:456-463.
60. Klassen L.J., Bilkey T.S., Katzman M.A., Chokka P. Comorbid attention deficit/hyperactivity disorder and substance use disorder: treatment considerations. Curr Drug Abuse Rev 2012, 5:190-198.
61. Alia-Klein N., Parvaz M.A., Woicik P.A., Konova A.B., Maloney T., Shumay E., Wang R., Telang F., Biegon A., Wang G.J., Fowler J.S., Tomasi D., Volkow N.D., Goldstein R.Z. Gene X disease interaction on orbitofrontal gray matter in cocaine addiction. Arch Gen Psychiatry 2011, 68:283-294.
62. Franklin T.R., Acton P.D., Maldjian J.A., Gray J.D., Croft J.R., Dackis C.A., O'Brien C.P., Childress A.R. Decreased gray matter concentration in the insular, orbitofrontal, cingulate, and temporal cortices of cocaine patients. Biol Psychiat 2002, 51:134-142.
63. Kim S.J., Lyoo I.K., Hwang J., Chung A., Sung Y.H., Kim J., Kwon D.H., Chang K.H., Renshaw P.F. Prefrontal grey-matter changes in short-term and long-term abstinent methamphetamine abusers. Int J Neuropsychopharmacol 2006, 9:221-228.
64. Morales A.M., Lee B., Hellemann G., O'Neill J., London E.D. Gray matter volume in methamphetamine dependence: cigarette smoking and changes with abstinence from methamphetamine. Drug Alcohol Depend 2012, 125:230-238.
65. Parvaz M.A., Konova A.B., Tomasi D., Volkow N.D., Goldstein R.Z. Structural integrity of the prefrontal cortex modulates electrocortical sensitivity to reward. J Cogn Neurosci 2012, 24:1560-1570.
66. Schwartz D.L., Mitchell A.D., Lahna D.L., Luber H.S., Huckans M.S., Mitchell S.H., Hoffman W.F. Global and local morphometric differences in recently abstinent methamphetamine-dependent individuals. Neuroimage 2010, 50:1392-1401.
67. Sim M.E., Lyoo I.K., Streeter C.C., Covell J., Sarid-Segal O., Ciraulo D.A., Kim M.J., Kaufman M.J., Yurgelun-Todd D.A., Renshaw P.F. Cerebellar gray matter volume correlates with duration of cocaine use in cocaine-dependent subjects. Neuropsychopharmacology 2007, 32:2229-2237.
68. Tanabe J., Tregellas J.R., Dalwani M., Thompson L., Owens E., Crowley T., Banich M. Medial orbitofrontal cortex gray matter is reduced in abstinent substance-dependent individuals. Biol Psychiatry 2009, 65:160-164.